Collegium Reports Q3 2026 Results, Reaffirms Guidance
Collegium reported third-quarter 2026 financial results and reaffirmed its 2026 guidance. Quarterly net revenue was $216.3 million, up 3% year over year.
Story updates
12:32:33 PM UTC
SquawkNews
Collegium reported Q3 2026 net revenue of $216.3M, up 3% year over year, and adjusted EBITDA of $121.6M. It reaffirmed full-year 2026 guidance and said it expects to complete its previously announced $50M accelerated share repurchase before year-end.Material DetailsContext by AI AnalystThis is a qu…
12:44:08 PM UTC
SquawkNews
*-- Earnings Flash (COLL) Collegium Pharmaceutical, Inc. Reports Q3 Revenue $216.3M, vs.